NOVATO, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that it has entered into an "At-the-Market" ("ATM") Sales Agreement, dated April 30, 2012, with Cowen and Company, LLC ("Cowen"), under which Raptor may, at its discretion, sell its common stock with a sales value of up to a maximum of $40 million through ATM sales on the NASDAQ Stock Market. Cowen will act as sole sales agent for any sales made under the ATM. The common stock will be sold at prevailing market prices at the time of the sale of common stock, and, as a result, prices may vary. The ATM places no restrictions on Raptor's ability to enter into and consummate other equity and debt financing transactions.
